Leadership & Pay ·
Three directors resign from Anavex board citing strategic disagreements
AVXLAnavex Life Sciences Corp.
On October 28, 2026, Dr. Jiong Ma, Mr. Gautam Patel, and Dr. Adrian Senderowicz resigned from the Board of Directors of Anavex Life Sciences Corp., effective immediately. The departures were driven by misalignments regarding the company's strategic direction and business plan execution. Following these resignations, the board reconstituted its standing committees on November 1, 2026, appointing Dr. Claus van der Velden, Dr. Peter Donhauser, and Dr. Axel Paeger to lead the Audit, Compensation, and Nominating & Corporate Governance Committees respectively. Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases.